Source: Life Care News

Conformis: Conformis Reports Second Quarter 2023 Financial Results

BILLERICA, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) - Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Summary Total revenue of $13.0 million, a decrease of 15% year-over-year on a reported and constant currency [...]

Read full article »

Conformis's Competitors | Conformis's News | Conformis's Financials

Followers on Owler

193

Est. Annual Revenue

$25-100M

Est. Employees

250-500

President & CEO

Mark Augusti

CEO Approval Rating

70/100

Conformis is a Massachusetts-based medical device company that designs and manufactures products such as implants and surgical instruments to treat knee and hip replacement.